Higher expression of CD2 in severe CFS/ME patients potentially implies that more NK cells in these patients are in an active state and may have a greater ability than the moderate CFS/ME patients to induce NK cell activation and cytotoxic activities [55]. The gene discussed is CD2; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.